文档介绍：左氧氟沙星治疗耐多药肺结核的效果与安全性
[摘要]目的 分析左氧氟沙星治療耐多药肺结核的效果与安全性。方法 选取2018年1月~2019年1月在我院接受治疗的80例耐多药肺结核患者作为研究对象,采用随机列表法将其分为对照组(ntwo groups were lower than those before treatment, and the differences were statistically significant (P<). The levels of TNF-α, IL-6 and IL-1 after treatment in the observation group were lower than those in the control group, and the differences were statistically significant (P<). During the drug treatment period, the total incidence rate of adverse reactions in the observation group was %, compared with % in the control group, and the difference was not statistically significant (P>). Conclusion Levofloxacin in the treatment of patients with multidrug-resistant pulmonary tuberculosis can significantly reduce the level of inflammatory factors and improve the therapeutic effect. At the same time, patients have fewer adverse reactions and have higher safety, which is worthy of being promoted and applied. [Key words] Multidrug-resistant pulmonary tuberculosis; Levofloxacin; Therapeutic effect; Adverse reactions; Inflammatory factors
肺结核是临床上常见的慢性疾病,由感染结核分枝杆菌所导致[1]。肺结核疾病具有广泛的传染性,可导致任何年龄段的人群感染,当患者感染肺结核疾病后,会出现咳嗽、咳痰、咯血、呼吸困难等多种临床症状,严重影响患者的身心健康和日常生活,并且成为我国严重的公共卫生问题[2]。临床上常采用合理的抗结核药物对患者治疗,以改善患者的病情,减少疾病的传染,但是患者在长期的治疗过程中,会出现耐药性,严重影响了疾病的治疗。对于耐多药肺结核疾病,需要选择敏感性较高的药物治疗,以提高对肺结核疾病的治疗效果,临床上常用于治疗耐多药性肺结核的药物为左氧氟沙星,其是一种对改善病情有重要作用的药物[3]。本研究主要研究左氧氟沙星治疗耐多